Your browser doesn't support javascript.
loading
Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges.
Song, Xueyi; Li, Xuehao; Ge, Yuexin; Song, Jia; Wei, Qian; He, Miao; Wei, Minjie; Zhang, Yining; Chen, Tianbao; Zhao, Lin.
Afiliação
  • Song X; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: 1317110911@qq.com.
  • Li X; Department of thoracic surgery, The First Affiliated Hospital of China Medical University, Shenyang, China. Electronic address: xhli92@cmu.edu.cn.
  • Ge Y; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: 1621914066@qq.com.
  • Song J; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: 2294465620@qq.com.
  • Wei Q; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: 584950932@qq.com.
  • He M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: hemiao_cmu@126.com.
  • Wei M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: mjwei@cmu.edu.cn.
  • Zhang Y; Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, China. Electronic address: zhangyining@cmu.edu.cn.
  • Chen T; Natural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland. Electronic address: UK.t.chen@qub.ac.uk.
  • Zhao L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China. Electronic address: lzhao@cmu.edu.cn.
Int Immunopharmacol ; 123: 110718, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37597404
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Processamento Alternativo / Neoplasias Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Processamento Alternativo / Neoplasias Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article